Dr. Greg Vigna Debridement for decubitus ulcers must align with treatment goals, with early reconstructive surgery recommended to avoid ris ...

By eliminating these obstructions, debridement creates an optimal environment for wound healing. This procedure can be performed using various methods, including mechanical, enzymatic, autolytic ...

Slow-healing wounds contain insufficient amounts of intrinsic collagenases to provide sufficient wound debridement, so that the use of products containing synergistic collagenases and proteases ...

“With no new FDA-approved drugs in this category since 1965, EscharEx has the potential to redefine the standard of care for chronic wound debridement. EscharEx has already demonstrated its ...

"With no new FDA-approved drugs in this category since 1965, EscharEx has the potential to redefine the standard of care for chronic wound debridement," CEO Ofer Gonen said, referring to the ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...